Question
Asked 11th Dec, 2014

Is targeting thermogenesis a viable treatment option for obesity/metabolic disease?

Overexpression of uncoupling proteins in small rodents is an effective way to alter thermogenesis. This strategy prevents diet induced obesity and insulin resistance (link 1). There is now substantial interest in alternative methods of increasing thermogenesis as a means to treat obesity (links 2 and 3). However, due to the volume : surface ratio, small rodents have a high tolerance for elevated thermogenesis (link 4) as a result of UCP overexpression. Humans have a much lower surface area : volume ratio and therefore have a reduced capacity to dissipate heat. Therefore, will overweight humans have a sufficient tolerance for enhanced thermogenesis for this to be a safe and viable treatment option?

Most recent answer

7th Dec, 2015
Ashley Solmonson
University of Texas Southwestern Medical Center
I agree that browning of white fat is one of the most promising options in reducing obesity through mechanisms of uncoupled respiration but it is well established that the mechanisms of thermogenesis in humans is different from that in rodents. There is evidence that in humans a significant amount of heat is produced by skeletal muscle and the actions of Uncoupling Protein 3 (UCP3).  One interesting idea is to look at the actions of UCP3 in skin, where it is endogenously expressed.  Our lab has data suggesting that overexpression of UCP3 in skin is sufficient to lower body weight and prevent diet-induced obesity.  There does not seem to be a change in body temperature in these animals presumably because they are able to dissipate excess heat externally.  

All Answers (12)

11th Dec, 2014
Tausif Alam
University of Wisconsin–Madison
"Humans have a much lower surface area : volume ratio and therefore have a reduced capacity to dissipate heat. Therefore, will overweight humans have a sufficient tolerance for enhanced thermogenesis for this to be a safe and viable treatment option?"
Overweight people will have even lower surface area to volume ratio than normal people! 
1 Recommendation
11th Dec, 2014
Michael Marcus Hoffmann
University Medical Center Freiburg
At the moment several groups are trying to develop strategies to increase the "browning" of fat. There exist several reviews:
Mol Cell Endocrinol. 2013 Oct 15;379(1-2):43-50.
Nat Rev Endocrinol. 2014 Jan;10(1):24-36.
1 Recommendation
11th Dec, 2014
Santosh Kumar Maurya
Sanford Burnham Prebys Medical Discovery Institute
This review provides a nice explanation:
11th Dec, 2014
Róbert Wagner
Universitätsklinikum Düsseldorf
In the 1930ies dinitrophenol, a protonophore which "leaks" the mitochondrial membrane, was used in the US as a diet-pill. There were several fatalities because of lethal hyperthermia, and chronic use led to blindness due to cataracts. I think adverse effects of even a slight hyperthermia, if it 's chronic, could be prohibitive in humans.
Hi David. Yes, definitely. You will not be able to measure an increase in body temperature - at least not systemically. Thus, re-activation of brown fat in humans - or maybe generating some active "beige" fat - represents one on the most promising and exciting approaches to fight obesity. Best wishes from Vienna, -harald
15th Dec, 2014
Tausif Alam
University of Wisconsin–Madison
One can also take L-Thyroxine to push the levels closer to the upper end of normal spectrum, which is more than likely to use up reserve energy (provided the intake remains the same), just as wasting energy by fooling the normal thermogenesis. Both approaches have similar theoretical potential and both are dangerous in the long-run.
Rather than "promising", a sure way to control obesity has always been the "boring" consumption of balanced diet combined with exercise.  ;)
1 Recommendation
17th Dec, 2014
Carlos Guillen
Complutense University of Madrid
Hi David!!. I think that at this moment this is hot topic in obesity field. Since several years ago that it was demonstrated that humans, under certain circumstances, could reactivate, the capacity to dissipate heat is fantastic by BAT. I remember you that scientific community thought for a long time that BAT dissapeared after birth in humans. Then, since 2009, BAT reactivation is one of the most exciting possibilities for burning fatty acids in mitochondria by increasing non-shivering thermogenesis
1 Recommendation
19th Dec, 2014
Reza Homayounfar
National Nutrition and Food Technology Research Institute of Iran
The nice article i have read recently
Moisan A, Lee Y-K, Zhang JD, Hudak CS, Meyer CA, Prummer M, et al. White-to-brown metabolic conversion of human adipocytes by JAK inhibition. Nature cell biology. 2014
1 Recommendation
20th Dec, 2014
Kasturi Sen Ray
Tata Institute of Social Sciences
Is a very interesting topic today. As per Herald, yes,  we may not be able to measure the temperature rise but using K4B2, we may measure the energy expenditure , change in  RQ  and the diet Induced thermogenic effect of specific food or ingredient. BAT is related to mainly adoptive thermogenesis for cold.
Use of L-Thyroxine may be an easy way of loosing body wt for normal people but if the obesity is resistant type due to hypothyroidism, L-Thyroxine will not be effective .
23rd Dec, 2014
Romesh Khardori
Eastern Virginia Medical School
Levothyroxine will lead to weight loss in Hypothyroidism primarily by facilitating weight loss by other means. Furthermore there are TH receptors in brown fat that suggests physiological role for thyroid hormone. In hypothyroid state weight loss induced by TH is not always related to thermognesis alone. Loss of retained fluid and better water clearance through improved renal blood flow are other reasons.
1 Recommendation
23rd Dec, 2014
Kulvinder kochar kaur
Dr kulvinder kaur centre for human reproduction,Jalandhar,Punjab,India.
although most of research on obesity is concenrating on white adipose tissue and the development,differentiation ie hypertrophy and hyperplasia of adipocytes and pfeadipocyytes in WAT and role of inflammation and macrophage infiltration directly or conversion of preadi[ocytes,metabolic endotoxemia,gut microbiota lreading to increased LPS absorption from increased GIT permeability with altered gut microbiota is some of the aetiopathogenesis with infiltration of Treg cells,cdt4. CHT8 cellsiNKT CELLS th17 all have ben found but importance is being given simultaneously to the microrna which affect the differentiATION OF BRITE AND BROWN ADIPOCYTES AND IMPORTANCE OF MIrna'S 26,155,27a,b,130 a ,miR155 etc in adipocyte differentiation and how further roles of FGF21 may affect thermogenesis and natriureteic peptides
1 Recommendation
7th Dec, 2015
Ashley Solmonson
University of Texas Southwestern Medical Center
I agree that browning of white fat is one of the most promising options in reducing obesity through mechanisms of uncoupled respiration but it is well established that the mechanisms of thermogenesis in humans is different from that in rodents. There is evidence that in humans a significant amount of heat is produced by skeletal muscle and the actions of Uncoupling Protein 3 (UCP3).  One interesting idea is to look at the actions of UCP3 in skin, where it is endogenously expressed.  Our lab has data suggesting that overexpression of UCP3 in skin is sufficient to lower body weight and prevent diet-induced obesity.  There does not seem to be a change in body temperature in these animals presumably because they are able to dissipate excess heat externally.  

Similar questions and discussions

Are there short term clinical trials that might have an impact on managing associated conditions in individuals with metabolic syndrome?
Question
15 answers
  • Richard G MathiasRichard G Mathias
Metabolic syndrome includes several features that are amenable to short term trials. Hypertension due to stimulation of sodium resorption by insulin on the renal distal tubule responds quickly reducing insulin levels with very low sugar (carbohydrate) ketogenic diets (VLCKD). A trial of persons with hypertension would help to answer the question of whether primary hypertension is caused by this functional hyperinsulinemia. For midwives and obstetricians, the observation of hypertension and pre-eclampsia may indicate that a small trial would be worthwhile in women at relatively low risk for eclampsia.
While type 2 diabetes responds well to VLCKD's in randomized clinical trials, determining whether the reductions in inflammatory markers will either slow or stop progression of Alzheimer's type or inflammatory dementia are urgently needed and a proof of concept trial would not take a large number of subjects as the clinical course is generally progressive. Prevention of inflammatory dementias would take a much larger randomized trial but as dementia is a complication of type 2 diabetes and by association, metabolic syndrome, there may be a reasonable assumption of a positive trial. There is some evidence that this will be efficacious but in a non-definitive trial. Likewise the mood disorder associated with metabolic syndrome could be tested in a relatively small clinical trial.
As the adverse effects of VLCKD's are minimal, applications for the ethics approval for such clinical trials should not be difficult to obtain.
For clinicians wishing to carry out clinical trials in relatively small numbers of individuals as a precursor to obtaining funding and ethics approval for larger, more definitive trials, these trials are important clinically as the conditions are common and the trials feasible for the same reasons. Positive trials may affect the management of patients commonly seen in clinical practice through well funded larger randomized controlled trials.
.

Related Publications

Article
Purpose of the study: Bofu-tsusho-San (Fang-feng-tong-sheng-san) has been used to treat obesity for about 700 years in China and Japan. In mice, the anti-obesity actions of Tsumura Bofu-tsusho-San extract granules (Tokyo, Japan)(TJ-62) have been shown to include promotion in brown adipose tissue (BAT) thermogenesis via l-ephedrine and d-pseudoephed...
Article
The ability to regulate body temperature diminishes with age. Exercise training is known to increase cardiovascular performance, and there is some evidence of a cross-adaption between exercise and cold tolerance in young rats. The present study was designed to examine the effects of physical training by treadmill running on the capacity for brown a...
Article
Full-text available
Uncoupling proteins (UCP) are evolutionary conserved mitochondrial carriers that control energy metabolism and therefore play important roles in several physiological processes such as thermogenesis, regulation of reactive oxygen species (ROS), growth control, lipid metabolism and regulation of insulin secretion. Despite their importance in various...
Got a technical question?
Get high-quality answers from experts.